BlackRock Health Sciences Term Trust Announces Dividend of $0.18 (NYSE:BMEZ)

BlackRock Health Sciences Term Trust (NYSE:BMEZ) announced a dividend on Thursday, January 2nd,NASDAQ Dividends reports. Stockholders of record on Wednesday, January 15th will be given a dividend of 0.1782 per share on Friday, January 31st. The ex-dividend date is Wednesday, January 15th.

BlackRock Health Sciences Term Trust has raised its dividend by an average of 20.7% per year over the last three years.

BlackRock Health Sciences Term Trust Stock Performance

BMEZ stock traded up $0.52 during trading on Friday, hitting $15.00. 722,833 shares of the stock traded hands, compared to its average volume of 513,116. BlackRock Health Sciences Term Trust has a 1 year low of $14.27 and a 1 year high of $16.59. The firm’s 50 day moving average is $15.33 and its two-hundred day moving average is $15.56.

Insider Activity at BlackRock Health Sciences Term Trust

In other BlackRock Health Sciences Term Trust news, major shareholder Saba Capital Management, L.P. acquired 29,795 shares of the company’s stock in a transaction that occurred on Wednesday, October 16th. The shares were bought at an average cost of $15.81 per share, with a total value of $471,058.95. Following the completion of the transaction, the insider now directly owns 20,750,913 shares of the company’s stock, valued at approximately $328,071,934.53. This represents a 0.14 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.